|
|
|
European Biopharmaceutical Review
|
'Robot' is a Czech word meaning worker, from the play RUR: Rossums' Universal Robots by the Bohemian writer Karel Capek. The robot has since become an inspiration for science fiction writers and for engineers. Of course the science fiction vision of a robot is a mechanical man, but the reality we see in industry is simply a robotic arm. This is a versatile programmable manipulator, an integration of mechanics, electronics and software, designed interdependently to produce the mechanical equivalent of the computer - an undedicated machine unable to do anything until we program it.
In the pharmaceutical lab it is even less than that definition; the term 'robot' being applied to programmable liquid handlers. Drug development requires the screening of hundreds or thousands of samples and it is in this field that the robot arm is a vital tool. Such an automated screening system is called a 'high-throughput screening' (HTS) system.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
5 |
| | | | | |
|
|
 |
News and Press Releases |
 |
New to the PPMA Show 2018: Bright Ideas - Ambassador Programme
A new initiative for PPMA Show visitors this year is the Bright Ideas -
Ambassador Programme - a free advice service for start-up ventures and
entrepreneurs.
More info >> |
|
 |
White Papers |
 |
|
Personalised Medicine - Pharma and Dx Firms Share Wider Horizons
DiagnostikNet-BB
Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
More info >> |
|
 |
Industry Events |
 |
Clinical Trial Supply East coast 2018
16-17 October 2018, King of Prussia, PA
This unique event brings together leading pharma, device and
biotech professionals from across the East Coast region, to collaboratively
enhance the clinical supply chain. Over the two days, delegates and speakers
will discuss how to select forecasting and planning technology, how to reduce
waste in clinical trials supplies, how to choose your packaging strategy, but
we will also discover all the new technologies that will disrupt your clinical
trials supplies.
More info >> |
|
|
